2024/09/20 16:44:01 | |
---|---|
Price | |
36.31 EUR | |
Difference | -2.16% (-0.80) |
ISIN | DE0005785802 |
Symbol | FME |
Exchange | Xetra |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,889 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 36.29 EUR (41) |
Ask (Ask size) | 36.31 EUR (128) |
Open | 37.03 EUR |
High | 37.12 EUR |
Low | 36.31 EUR |
Close (prev. day) | 37.11 EUR |
VWAP | 36.54017 EUR |
Volume (pcs) | 205,818 |
Trading volume | 7,520,624.79 |
Number of trades | 1,524 |
Last size | 88 |
Related Futures | 39 |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/20 16:44:01 | |
---|---|
Price | |
36.31 EUR | |
Difference | -2.16% (-0.80) |
ISIN | DE0005785802 |
Symbol | FME |
Exchange | Xetra |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 10,889 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 36.29 EUR (41) |
Ask (Ask size) | 36.31 EUR (128) |
Open | 37.03 EUR |
High | 37.12 EUR |
Low | 36.31 EUR |
Close (prev. day) | 37.11 EUR |
VWAP | 36.54017 EUR |
Volume (pcs) | 205,818 |
Trading volume | 7,520,624.79 |
Number of trades | 1,524 |
Last size | 88 |
6m | 1Y | 3Y | |
Perf (%) | +3.23% | -12.48% | -38.27% |
Perf (abs.) | +1.16 | -5.29 | -23.01 |
Beta | 0.45 | 0.57 | 0.59 |
Volatility | 29.03 | 36.07 | 33.66 |
Ø price 5 days | Ø volume 5 days (pcs.) | 37.40 EUR (280,350) |
Ø price 30 days | Ø volume 30 days (pcs.) | 35.26 EUR (279,667) |
Ø price 100 days | Ø volume 100 days (pcs.) | 36.82 EUR (386,941) |
Ø price 250 days | Ø volume 250 days (pcs.) | 36.47 EUR (443,567) |
YTD High | date | 42.12 EUR (2024/05/16) |
YTD Low | date | 32.51 EUR (2024/08/08) |
52 Weeks High | date | 43.38 EUR (2023/09/20) |
52 Weeks Low | date | 30.16 EUR (2023/10/11) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/09/20 | 16:44 | 36.31 EUR | 7.52 | 1,524 |
Vienna Stock Exchange | 2024/09/20 | 15:30 | 36.48 EUR | 0.00 | 3 |
Tradegate | 2024/09/20 | 16:26 | 36.41 EUR | 0.21 | 44 |
Stuttgart | 2024/09/20 | 16:45 | 36.30 EUR | 0.02 | 40 |
SIX Swiss Exchange | 2019/06/25 | 17:31 | 75.28 CHF | 0.02 | 3 |
SIX Swiss Exchange | - | - | - | 0.00 | - |
Munich | 2024/09/20 | 08:00 | 36.88 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/09/20 | 13:34 | 36.51 EUR | 0.02 | 1 |
Hanover | 2024/09/20 | 08:16 | 37.02 EUR | 0.00 | 1 |
Hamburg | 2024/09/20 | 08:16 | 37.02 EUR | 0.00 | 1 |
Frankfurt | 2024/09/20 | 09:23 | 36.87 EUR | 0.01 | 2 |
FINRA other OTC Issues | 2024/09/16 | 20:56 | 39.70 USD | 0.04 | 1 |
Euronext Milan MTF Trading After Hours | 2024/06/10 | 19:12 | 40.45 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/09/20 | 10:21 | 36.93 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/20 | 16:31 | 36.39 EUR | 0.00 | 4 |
Berlin | 2024/09/20 | 16:40 | 36.37 EUR | 0.00 | 11 |
FRESENIUS MEDICAL CARE AG |
- - |
Else-Kröner-Strasse 1 - 61352 Bad Homburg |
Telefon: +49-6172-609-0 |
Fax: + |
E-mail: marketing.international@freseniusmedicalcare.com |
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany. |
Helen Ping Giza | Chairman of Managing Board |
Frank Maddux | Member of Executive Committee |
Craig Cordola | Member of Executive Committee |
Jörg Häring | Member of Executive Committee |
M.D.,Ph.D. Katarzyna Mazur-Hofsaess | Member of Executive Committee |
Martin Fischer | Member of Executive Committee |
Michael Sen | Chairman of Supervisory Board |
A. Sorensen | Member of Supervisory Board |
Manuela Stauss-Grabo | Member of Supervisory Board |
Marcus Kuhnert | Member of Supervisory Board |
Beate Haßdenteufel | Member of Supervisory Board |
Frank Prescher | Member of Supervisory Board |
Pascale Witz | Member of Supervisory Board |
Ralf Erkens | Member of Supervisory Board |
Regina Karsch | Member of Supervisory Board |
Sara Hennicken | Member of Supervisory Board |
Shervin Korangy | Member of Supervisory Board |
Stefanie Lang | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer